Differential localization and characterization of functional calcitonin gene-related peptide receptors in human subcutaneous arteries

Acta Physiologica

Volumn 210, Issue 4, 2014, Pages 811-822

  Edvinsson, L ^a   Ahnstedt, H ^a   Larsen, R ^b   Sheykhzade, M ^b  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Affinity; Calcitonin gene related peptide; Human subcutaneous artery; MK 0974; Telcagepant

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN RECEPTOR LIKE RECEPTOR; FURA 2; INDOMETACIN; NITRIC OXIDE; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; TELCAGEPANT;

ADULT; AGED; ARTERY; ARTICLE; BLOOD FLOW; CIRCULATION; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; SMOOTH MUSCLE FIBER; SUBCUTANEOUS ARTERY; VASCULAR SMOOTH MUSCLE; VASODILATATION; YOUNG ADULT;

AFFINITY; CALCITONIN GENE-RELATED PEPTIDE; HUMAN SUBCUTANEOUS ARTERY; MK-0974; TELCAGEPANT;

ADULT; AGED; ARTERIES; AZEPINES; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; SUBCUTANEOUS TISSUE; YOUNG ADULT;

EID: 84896044767     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12213     Document Type: Article

References (38)

1. Alexander, S.P., Mathie, A. & Peters, J.A. 2011. Guide to receptors and channels (GRAC), 5th edition. Br J Pharmacol 164(Suppl 1), S1-S324.
2. Arunlakshana, O. & Schild, H.O. 1959. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 14, 48-58.
3. Bouschet, T., Martin, S. & Henley, J.M. 2012. Regulation of calcium sensing receptor trafficking by RAMPs. Adv Exp Med Biol 744, 39-48.
4. Brain, S.D., Williams, T.J., Tippins, J.R., Morris, H.R. & MacIntyre, I. 1985. Calcitonin gene-related peptide is a potent vasodilator. Nature 313, 54-56.
5. Brøndum, E., Kold-Petersen, H., Simonsen, U. & Aalkjaer, C. 2010. NS309 restores EDHF-type relaxation in mesenteric small arteries from type 2 diabetic ZDF rats. Br J Pharmacol 159, 154-165.
6. Chan, K.Y., Edvinsson, L., Eftekhari, S., Kimblad, P.O., Kane, S.A., Lynch, J., Hargreaves, R.J., de Vries, R., Garrelds, I.M., van den Bogaerdt, A.J., Danser, A.H. & Maassenvandenbrink, A. 2010. Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries. J Pharmacol Exp Ther 334, 746-752.
7. Christopoulos, A., Christopoulos, G., Morfis, M., Udawela, M., Laburthe, M., Couvineau, A., Kuwasako, K., Tilakaratne, N. & Sexton, P.M. 2003. Novel receptor partners and function of receptor activity-modifying proteins. J Biol Chem 278, 3293-3297.
8. Edvinsson, M.L. & Edvinsson, L. 2008. Comparison of CGRP and NO responses in the human peripheral microcirculation of migraine and control subjects. Cephalalgia 28, 563-566.
9. Edvinsson, L. & MacKenzie, E.T. 2002. General and Comparative Anatomy of the Cerebral Circulation, Lippincott Williams & Wilkins, Philadelphia.
10. Edvinsson, L., Sams, A., Jansen-Olesen, I., Tajti, J., Kane, S.A., Rutledge, R.Z., Koblan, K.S., Hill, R.G. & Longmore, J. 2001. Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries. Eur J Pharmacol 415, 39-44.
11. Edvinsson, L., Alm, R., Shaw, D., Rutledge, R.Z., Koblan, K.S., Longmore, J. & Kane, S.A. 2002. Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells. Eur J Pharmacol 434, 49-53.
12. Edvinsson, L., Chan, K.Y., Eftekhari, S., Nilsson, E., de Vries, R., Saveland, H., Dirven, C.M., Danser, A.H. & MaassenVanDenBrink, A. 2010. Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries. Cephalalgia 30, 1233-1240.
13. Eftekhari, S. & Edvinsson, L. 2011. Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level. BMC Neurosci 12, 112.
14. Eftekhari, S., Salvatore, C.A., Calamari, A., Kane, S.A., Tajti, J. & Edvinsson, L. 2010. Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion. Neuroscience 169, 683-696.
15. Fernandes, E.S., Schmidhuber, S.M. & Brain, S.D. 2009. Sensory-nerve-derived neuropeptides: possible therapeutic targets. Handb Exp Pharmacol 194, 393-416.
16. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260, 3440-3450.
17. Gupta, S., Mehrotra, S., Villalon, C.M., Garrelds, I.M., de Vries, R., van Kats, J.P., Sharma, H.S., Saxena, P.R. & Maassenvandenbrink, A. 2006. Characterisation of CGRP receptors in human and porcine isolated coronary arteries: evidence for CGRP receptor heterogeneity. Eur J Pharmacol 530, 107-116.
18. ter Haar, E., Koth, C.M., Abdul-Manan, N., Swenson, L., Coll, J.T., Lippke, J.A., Lepre, C.A., Garcia-Guzman, M. & Moore, J.M. 2010. Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism. Structure 18, 1083-1093.
19. Högestätt, E.D., Andersson, K.E. & Edvinsson, L. 1983. Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand 117, 49-61.
20. Holzer, P. 1988. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 24, 739-768.
21. 2+]i and force in rat resistance arteries. Pflugers Arch 420, 536-543.
22. Kawasaki, J., Kobayashi, S., Miyagi, Y., Nishimura, J., Fujishima, M. & Kanaide, H. 1997. The mechanisms of the relaxation induced by vasoactive intestinal peptide in the porcine coronary artery. Br J Pharmacol 121, 977-985.
23. Kenakin, T. 1997. Analysis of Drug-Receptor Interaction, 3rd edn. Lippincott-Raven Publishers, New York, NY.
24. Lenhart, P.M., Broselid, S., Barrick, C.J., Leeb-Lundberg, L.M. & Caron, K.M. 2013. G-protein-coupled receptor 30 interacts with receptor activity-modifying protein 3 and confers sex-dependent cardioprotection. J Mol Endocrinol 51, 191-202.
25. Lennerz, J.K., Ruhle, V., Ceppa, E.P., Neuhuber, W.L., Bunnett, N.W., Grady, E.F. & Messlinger, K. 2008. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507, 1277-1299.
26. Mallee, J.J., Salvatore, C.A., LeBourdelles, B., Oliver, K.R., Longmore, J., Koblan, K.S. & Kane, S.A. 2002. Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists. J Biol Chem 277, 14294-14298.
27. McLatchie, L.M., Fraser, N.J., Main, M.J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M.G. & Foord, S.M. 1998. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393, 333-339.
28. Moore, E.L. & Salvatore, C.A. 2012. Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine. Br J Pharmacol 166, 66-78.
29. Mulvany, M.J. & Halpern, W. 1977. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41, 19-26.
30. Nilsson, T., Lind, H., Brunkvall, J. & Edvinsson, L. 2000. Vasodilation in human subcutaneous arteries induced by neuropeptide Y is mediated by neuropeptide Y Y1 receptors and is nitric oxide dependent. Can J Physiol Pharmacol 78, 251-255.
31. Oliver, K.R., Wainwright, A., Edvinsson, L., Pickard, J.D. & Hill, R.G. 2002. Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J Cereb Blood Flow Metab 22, 620-629.
32. Roe, M.W., Lemasters, J.J. & Herman, B. 1990. Assessment of Fura-2 for measurements of cytosolic free calcium. Cell Calcium 11, 63-73.
33. Salvatore, C.A., Hershey, J.C., Corcoran, H.A., Fay, J.F., Johnston, V.K., Moore, E.L., Mosser, S.D., Burgey, C.S., Paone, D.V., Shaw, A.W., Graham, S.L., Vacca, J.P., Williams, T.M., Koblan, K.S. & Kane, S.A. 2008. Pharmacological characterization of MK-0974 [N-[(3R, 6S)-6-(2, 3-difluorophenyl)-2-oxo-1-(2, 2, 2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2, 3-dihydro-1H-imidazo[4, 5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine. J Pharmacol Exp Ther 324, 416-421.
34. Sheykhzade, M. & Berg Nyborg, N.C. 2001. Mechanism of CGRP-induced relaxation in rat intramural coronary arteries. Br J Pharmacol 132, 1235-1246.
35. Sheykhzade, M., Lind, H. & Edvinsson, L. 2004. Noncompetitive antagonism of BIBN4096BS on CGRP-induced responses in human subcutaneous arteries. Br J Pharmacol 143, 1066-1073.
36. Tuo, Y., Guo, X., Zhang, X., Wang, Z., Zhou, J., Xia, L., Zhang, Y., Wen, J. & Jin, D. 2013. The biological effects and mechanisms of calcitonin gene-related peptide on human endothelial cell. J Recept Signal Transduct Res 33, 114-123.
37. Verheggen, R., Bumann, K. & Kaumann, A.J. 2002. BIBN4096BS is a potent competitive antagonist of the relaxant effects of alpha-CGRP on human temporal artery: comparison with CGRP(8-37). Br J Pharmacol 136, 120-126.
38. Willis, W.D. Jr 1999. Dorsal root potentials and dorsal root reflexes: a double-edged sword. Exp Brain Res 124, 395-421.